Screener
Avalo Therapeutics AVTX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $971.41M.
The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001534120-26-000049
FAQ
- What is Avalo Therapeutics's market capitalization?
- Avalo Therapeutics (AVTX) reported market capitalization of $971.41M in Q2 2026.
- How has Avalo Therapeutics's market capitalization changed year-over-year?
- Avalo Therapeutics's market capitalization increased by 1712.4% year-over-year, from $53.6M to $971.41M.
- What is the long-term trend for Avalo Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Avalo Therapeutics's market capitalization has grown at a 5.6% compound annual growth rate (CAGR), from $250.44M to $329.31M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Avalo Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude